Makes biological indicators for pharmaceutical and medical device manufacturers.
Jun 2026Revenue $250M/yrExpenses $227M/yr
No trend
Figures by year
Is Mesa Laboratories profitable?
Yes. In the 12 months to Jun 2026, revenue was $250M and expenses $227M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Mar 2026 | $249M | $231M | $18.5M |
| Mar 2025 | $241M | $225M | $16.3M |
| Mar 2024 | $216M | $488M | −$272M |
| Mar 2023 | $219M | $216M | $3.32M |
| Mar 2022 | $184M | $180M | $4.70M |
| Mar 2021 | $134M | $122M | $12.4M |
| Mar 2020 | $118M | $110M | $7.92M |
| Mar 2019 | $103M | $93.4M | $9.78M |
| Mar 2018 | $96.2M | $94.0M | $2.18M |
| Mar 2017 | $93.7M | $77.4M | $16.3M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.